These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34103974)

  • 1. High Levels of Serum IgG for
    Titapun A; Luvira V; Srisuk T; Jareanrat A; Thanasukarn V; Thanee M; Sa-Ngiamwibool P; Padthaisong S; Duangkumpha K; Suksawat M; Loilome W; Sithithaworn P; Techasen A; Thinkhamrop B; Dzienny A; Caglayan A; Park D; Mahmud S; Khuntikeo N
    Int J Gen Med; 2021; 14():2191-2204. PubMed ID: 34103974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum IgG as a Marker for
    Titapun A; Techasen A; Sa-Ngiamwibool P; Sithithaworn P; Luvira V; Srisuk T; Jareanrat A; Dokduang H; Loilome W; Thinkhamrop B; Khuntikeo N
    Int J Gen Med; 2020; 13():1271-1283. PubMed ID: 33273846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma.
    Padthaisong S; Thanee M; Namwat N; Phetcharaburanin J; Klanrit P; Khuntikeo N; Titapun A; Sungkhamanon S; Saya H; Loilome W
    J Transl Med; 2020 Feb; 18(1):64. PubMed ID: 32039729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mismatch Repair Deficiency Is a Prognostic Factor Predicting Good Survival of
    Khuntikeo N; Padthaisong S; Loilome W; Klanrit P; Ratchatapusit S; Techasen A; Jareanrat A; Thanasukarn V; Srisuk T; Luvira V; Chindaprasirt J; Sa-Ngiamwibool P; Aphivatanasiri C; Intarawichian P; Koonmee S; Prajumwongs P; Titapun A
    Cancers (Basel); 2023 Oct; 15(19):. PubMed ID: 37835526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Potential Biomarkers for
    Aksorn N; Roytrakul S; Kittisenachai S; Leelawat K; Chanvorachote P; Topanurak S; Hamano S; Lek-Uthai U
    In Vivo; 2018; 32(4):871-878. PubMed ID: 29936472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of CD44 Variant 9: A Novel Cancer Stem Cell Marker in Human Cholangiocarcinoma in Relation to Inflammation.
    Suwannakul N; Ma N; Thanan R; Pinlaor S; Ungarreevittaya P; Midorikawa K; Hiraku Y; Oikawa S; Kawanishi S; Murata M
    Mediators Inflamm; 2018; 2018():4867234. PubMed ID: 30402042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating miR-192 in liver fluke-associated cholangiocarcinoma patients: a prospective prognostic indicator.
    Silakit R; Loilome W; Yongvanit P; Chusorn P; Techasen A; Boonmars T; Khuntikeo N; Chamadol N; Pairojkul C; Namwat N
    J Hepatobiliary Pancreat Sci; 2014 Dec; 21(12):864-72. PubMed ID: 25131257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel carbohydrate antigen expression during development of Opisthorchis viverrini- associated cholangiocarcinoma in golden hamster: a potential marker for early diagnosis.
    Sawanyawisuth K; Silsirivanit A; Kunlabut K; Tantapotinan N; Vaeteewoottacharn K; Wongkham S
    Parasitol Int; 2012 Mar; 61(1):151-4. PubMed ID: 21784171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microproteinuria during Opisthorchis viverrini infection: a biomarker for advanced renal and hepatobiliary pathologies from chronic opisthorchiasis.
    Saichua P; Sithithaworn P; Jariwala AR; Diemert DJ; Sithithaworn J; Sripa B; Laha T; Mairiang E; Pairojkul C; Periago MV; Khuntikeo N; Mulvenna J; Bethony JM
    PLoS Negl Trop Dis; 2013; 7(5):e2228. PubMed ID: 23717698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic and transcriptional alterations of cholangiocarcinoma.
    Ito T; Sakurai-Yageta M; Goto A; Pairojkul C; Yongvanit P; Murakami Y
    J Hepatobiliary Pancreat Sci; 2014 Jun; 21(6):380-7. PubMed ID: 24532422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PRKAR1A overexpression is associated with increased ECPKA autoantibody in liver fluke-associated cholangiocarcinoma: application for assessment of the risk group.
    Loilome W; Yooyuen S; Namwat N; Sithithaworn P; Puapairoj A; Kano J; Noguchi M; Miwa M; Yongvanit P
    Tumour Biol; 2012 Dec; 33(6):2289-98. PubMed ID: 22922884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MTHFR polymorphisms and Opisthorchis viverrini infection: a relationship with increased susceptibility to cholangiocarcinoma in Thailand.
    Songserm N; Promthet S; Sithithaworn P; Pientong C; Ekalaksananan T; Chopjitt P; Parkin DM
    Asian Pac J Cancer Prev; 2011; 12(5):1341-5. PubMed ID: 21875294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival of Patients with Cholangiocarcinoma Receiving Surgical Treatment in an O. viverrini Endemic Area in Thailand: A Retrospective Cohort Study.
    Chansitthichok S; Chamnan P; Sarkhampee P; Lertsawatvicha N; Voravisutthikul P; Wattanarath P
    Asian Pac J Cancer Prev; 2020 Apr; 21(4):903-909. PubMed ID: 32334449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics of Opisthorchis viverrini-related cholangiocarcinoma.
    Jusakul A; Kongpetch S; Teh BT
    Curr Opin Gastroenterol; 2015 May; 31(3):258-63. PubMed ID: 25693006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycoproteomics analysis of plasma proteins associated with Opisthorchis viverrini infection-induced cholangiocarcinoma in hamster model.
    Sriwanitchrak P; Paemanee A; Roytrakul S; Viyanant V; Na-Bangchang K
    Asian Pac J Trop Med; 2016 Dec; 9(12):1165-1171. PubMed ID: 27955744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CP-673451, a Selective Platelet-Derived Growth Factor Receptor Tyrosine Kinase Inhibitor, Induces Apoptosis in
    Duangdara J; Boonsri B; Sayinta A; Supradit K; Thintharua P; Kumkate S; Suriyonplengsaeng C; Larbcharoensub N; Mingphruedhi S; Rungsakulkij N; Muangkaew P; Tangtawee P; Vassanasiri W; Suragul W; Janvilisri T; Tohtong R; Bates DO; Wongprasert K
    Pharmaceuticals (Basel); 2023 Dec; 17(1):. PubMed ID: 38275995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of salivary antibodies to crude antigens of Opisthorchis viverrini in opisthorchiasis and cholangiocarcinoma patients.
    Chaiyarit P; Sithithaworn P; Thuwajit C; Yongvanit P
    Clin Oral Investig; 2011 Aug; 15(4):477-83. PubMed ID: 20446100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma phosphoproteome and differential plasma phosphoproteins with opisthorchis viverrini-related cholangiocarcinoma.
    Kotawong K; Thitapakorn V; Roytrakul S; Phaonakrop N; Viyanant V; Na-Bangchang K
    Asian Pac J Cancer Prev; 2015; 16(3):1011-8. PubMed ID: 25735322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholangiocarcinoma in experimental hamsters with long-standing Opisthorchis viverrini infection.
    Songserm N; Prasongwattana J; Sithithaworn P; Sripa B; Pipitkool V
    Asian Pac J Cancer Prev; 2009; 10(2):299-302. PubMed ID: 19537899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulin Expression in Hamsters during Opisthorchis viverrini Infection-Induced Cholangiocarcinogenesis.
    Upontain S; Sereerak P; Laha T; Sripa B; Tangkawatana P; Brindley PJ; Tangkawatana S
    Asian Pac J Cancer Prev; 2018 Sep; 19(9):2437-2445. PubMed ID: 30255697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.